高分子量透明质酸对小鼠腹膜炎诱导脓毒症的治疗作用
本研究在小鼠盲肠结扎穿孔(CLP)诱导的腹膜炎脓毒症模型中,于CLP后4小时腹腔注射高分子量透明质酸(HMW HA,20 mg/kg)或磷酸盐缓冲液(PBS),评估生存、生理指标、器官损伤、细菌负荷及炎症因子。HMW HA显著改善血氧、肺组织学和生存率,并在CLP后24小时显著降低血浆炎症因子及肺、脾细菌负荷,CLP后6小时显著降低腹腔灌洗液细菌负荷。体外实验中,HMW HA(500 μg/mL)通过增加ezrin/radixin/moesin磷酸化增强RAW264.7细胞对大肠埃希菌的吞噬,ezrin抑制可消除该效应。作者结论认为腹腔给予HMW HA通过抑制炎症和增强抗菌活性对CLP诱导脓毒症发挥治疗作用。
要点
- 小鼠CLP脓毒症模型中,CLP后4小时腹腔注射HMW HA(20 mg/kg)显著改善血氧、肺组织学和生存率。
- CLP后24小时,HMW HA显著降低血浆炎症因子水平及肺、脾细菌负荷;CLP后6小时显著降低腹腔灌洗液细菌负荷。
- 体外LPS预处理的RAW264.7细胞中,HMW HA(500 μg/mL)显著增加对10 CFU大肠埃希菌的吞噬,部分通过增加ezrin/radixin/moesin磷酸化实现。
- ezrin抑制可消除HMW HA增强的RAW264.7细胞吞噬作用。
- 作者结论:腹腔给予HMW HA通过抑制炎症和增强抗菌活性对CLP诱导脓毒症发挥治疗作用。
适用人群与场景
- C57BL/6小鼠,CLP诱导的腹膜炎脓毒症模型。
- 体外实验:LPS预处理的RAW264.7细胞。
处置流程与药物剂量
- CLP后4小时腹腔注射HMW HA(20 mg/kg)溶液或PBS。
- 体外:LPS预处理的RAW264.7细胞先暴露于PBS或HMW HA(500 μg/mL),再暴露于10 CFU大肠埃希菌。
研究设计与关键结果
- 动物实验:CLP小鼠中,HMW HA腹腔灌注显著改善血氧、肺组织学和生存率。
- CLP后24小时,HMW HA显著降低血浆炎症因子水平及肺、脾细菌负荷。
- CLP后6小时,HMW HA显著降低腹腔灌洗液细菌负荷。
- 体外:HMW HA(500 μg/mL)显著增加LPS预处理的RAW264.7细胞对大肠埃希菌的吞噬,部分通过增加ezrin/radixin/moesin磷酸化;ezrin抑制消除该增强吞噬作用。
证据类型、等级与局限
- 证据类型:动物实验(小鼠CLP脓毒症模型)及体外细胞实验。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Intra-abdominal infection is the second most common cause of sepsis, and the mortality rate from abdominal sepsis remains high. High molecular weight (HMW) hyaluronic acid (HA) has been studied in sterile injury models as an anti-inflammatory and anti-permeability agent. This study evaluated the therapeutic effects of intraperitoneal HMW HA administration in mice with peritonitis-induced sepsis. Sepsis was induced in C57BL/6 mice by cecal ligation and puncture (CLP), followed 4 h later by an intraperitoneal injection of HMW HA (20 mg/kg) solution or phosphate buffered saline (PBS). Survival, physiological data, organ injury, bacterial burden, and inflammatory cytokine levels were assessed in the CLP mice. To assess the effect of HA on macrophage phagocytosis activity, RAW264.7 cells, primed with lipopolysaccharide, were exposed with either PBS or HMW HA (500 μg/mL) prior to exposure to 10 CFU of E coli bacteria. HMW HA instillation significantly improved blood oxygenation, lung histology, and survival in CLP mice. Inflammatory cytokine levels in the plasma and bacterial burdens in the lung and spleen were significantly decreased by HA administration at 24 h after CLP. At 6 h after CLP, HA significantly decreased bacterial burden in the peritoneal lavage fluid. HMW HA administration significantly increased E coli bacterial phagocytosis by RAW264.7 cells in part through increased phosphorylation of ezrin/radixin/moesin, a known downstream target of CD44 (a HA receptor); ezrin inhibition abolished the enhanced phagocytosis by RAW264.7 cells induced by HA. Intraperitoneal administration of HMW HA had therapeutic effects against CLP-induced sepsis in terms of suppressing inflammation and increasing antimicrobial activity.
参考来源
- Lee JH, Liu A, Park JH, et al. Therapeutic Effects of Hyaluronic Acid in Peritonitis-Induced Sepsis in Mice. Shock. 2020. PMID: 31977961. doi:10.1097/SHK.0000000000001512
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。